NCT06893991

Brief Summary

The goal of this clinical trial is to evaluate whether the synbiotic beverage "Daygurt" can improve lipid profiles, blood sugar levels, blood pressure, and body weight in individuals diagnosed with dyslipidemia. The main questions it aims to answer are: Does "Daygurt" significantly reduce total cholesterol and LDL levels compared to nutrition counseling alone? Does "Daygurt" increase HDL levels and reduce triglycerides more effectively than nutrition counseling? Does "Daygurt" lead to greater improvements in fasting blood sugar, blood pressure, and body weight compared to nutrition counseling? The intervention group (receiving "Daygurt" plus nutrition counseling) will be compared to the comparison group (receiving nutrition counseling without "Daygurt") to see if "Daygurt" provides additional benefits beyond standard dietary advice. Participants will be divided into 2 groups: Intervention group: Consume "Daygurt" daily for 8 weeks. Comparison group: Receive nutrition counseling sessions focused on managing dyslipidemia but will not consume "Daygurt." Both groups will undergo health parameter measurements before and after the intervention, including: Total cholesterol, LDL, HDL, and triglyceride levels. Fasting blood sugar. Blood pressure. Body mass index (BMI).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 27, 2025

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 5, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 25, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2025

Completed
Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

4 months

First QC Date

March 5, 2025

Last Update Submit

March 23, 2025

Conditions

Keywords

Symbiotic BeveragesLipid ProfileBody Mass Index

Outcome Measures

Primary Outcomes (1)

  • Lipid profile

    Fasting Total blood cholesterol, LDL cholesterol, HDL cholesterol and triglyceride level measured before and after intervention phase

    6 weeks (before and after intervention)

Study Arms (2)

Intervention Group

EXPERIMENTAL

Consuming 100 ml Symbiotic beverages every day for 6 weeks plus dietary advice to overcome dyslipidemia

Dietary Supplement: SYMBIONICBehavioral: Dietary advice

Comparison group

ACTIVE COMPARATOR

Receiving standard dietary advice to overcome dyslipidemia, but without drinking symbiotic beverage

Behavioral: Dietary advice

Interventions

SYMBIONICDIETARY_SUPPLEMENT

Provision of 100 ml symbiotic beverages "daygurt" per day for 6 weeks, plus standard dietary advice for dyslipidemia

Intervention Group
Dietary adviceBEHAVIORAL

Participants get standard dietary advice for dyslipidemia

Comparison groupIntervention Group

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Cholesterol total above 200 mg/dl, or LDL Cholesterol above 100, or BMI above 25 kg/m2
  • Agree to study protocols

You may not qualify if:

  • Has Allergic to dairy product
  • Having any drug lowering cholesterol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Ministry Polytechnic of Padang

Padang, West Sumatra, 25146, Indonesia

Location

MeSH Terms

Interventions

Nutrition Assessment

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: This trial is a controlled clinical studies conducted to evaluate the effectiveness of the symbiotic drink for improving lipid profiles, blood sugar and nutritional status in participants with hypercholesterolemia or overweight under study and to determine the common short-term side effects and risks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Dr

Study Record Dates

First Submitted

March 5, 2025

First Posted

March 25, 2025

Study Start

February 27, 2025

Primary Completion

June 15, 2025

Study Completion

October 15, 2025

Last Updated

March 25, 2025

Record last verified: 2025-03

Locations